
Lily Dara
@lilydaramd
Physician Scientist, practicing Hepatologist & GI. Research focus: mechanistic & translational, DILI, Cell Death, Checkpoint Inhibitor DILI (ILICI), AIH & PBC.
ID: 1293337887203721217
12-08-2020 00:07:40
747 Tweet
891 Followers
466 Following





A great way to start the #Persian New Year 🌸🪻🌼 Excellent autoimmune and cholestatic liver disease session with an inspiring Keynote talk by Dr. Patrick Kamath on loving what you do and finding joy in your career CLDFoundation #liverconnect Raj VuppaLanchi Christopher Bowlus, MD



DILI harms patients and remains a TOP reason drugs are withdrawn from the market. Recommend this article by Naga Chalasani et al in HEPATOLOGY Journal reviewing preclinical and clinical testing, DILI adjudication during trials, and how regulators approach NDAs. journals.lww.com/hep/Fulltext/9…


📡The #InternationalSeminarLiverSeriesonLiverToxicityandSteatoticLiverDisease with 𝗩𝗼𝗹𝗸𝗲𝗿 𝗠。 𝗟𝗮𝘂𝘀𝗰𝗵𝗸𝗲 is now available! Catch up here! 😃💻⏏️👇 youtu.be/GFyVFPBNhg0 EASLnews IBIMA Plataforma BIONAND Lily Dara Halt-RONIN EU project CIBERehd



USC Pancreatitis expert Dr. Buxbaum quoted during the Digestive Disease Week 2025 Post Grad Course


Go Paul Yoon! #proudmentormoment Super star resident and liver researcher. Got a poster of distinction. I have the most amazing and talented mentees 🫶🙌❤️ USC Division of GI & Liver AASLD #ddw #ddw2025 #liversquad Paul Yoon Digestive Disease Week



Submitting papers is painful! For #livertwitter: 1. Submit your best work to hepatology 2. If it doesn’t work out, can transfer seemlessly to Hepatology Communications 3. Lightning fast decisions, never re-doing peer review 4. If you submit elsewhere, send us the reports. We use them
